ZYNYZ 25 mg/mL
retifanlimab-dlwr · INJECTION · Incyte Corporation
No Recall History
Plain English
ZYNYZ is a injection containing retifanlimab-dlwr at 25 mg/mL, taken intravenous. Manufactured by Incyte Corporation.
Key Facts
- Brand Name
- ZYNYZ
- Generic Name
- retifanlimab-dlwr
- NDC Code (Product)
50881-006- Manufacturer
- Incyte Corporation
- Strength
- 25 mg/mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761334
- Drug Class
- Programmed Death Receptor-1 Blocking Antibody [EPC]
- Marketing Start
- 03/22/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is ZYNYZ used for?
ZYNYZ contains retifanlimab-dlwr. It is a injection taken intravenous. Consult your doctor for specific uses.
Is ZYNYZ a controlled substance?
ZYNYZ is not classified as a controlled substance by the DEA.
What is the generic name for ZYNYZ?
The generic name for ZYNYZ is retifanlimab-dlwr. There are no other listed brand versions of retifanlimab-dlwr.
What is the NDC code for ZYNYZ 25 mg/mL?
The NDC (National Drug Code) for ZYNYZ 25 mg/mL is 50881-006, listed by Incyte Corporation.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)